2 weeks Ago By Defense World Staff
Cerity Partners LLC cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 15.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor owned 11,626 shares of the company’s stock after selling 2,095 shares during the period. Cerity Partners LLC’s holdings in Privia Health Group were worth $213,000 as of its most recent SEC filing. A number of other hedge funds have also recently bought and sold shares of PRVA.
Barclays PLC lifted its position in shares of Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares in the last quarter.
Virtu Financial LLC bought a new position in shares of Privia Health Group during the 3rd quarter worth approximately $263,000. Franklin Resources Inc. boosted its stake in shares of Privia Health Group by 2.
2% in the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock worth $23,092,000 after buying an additional 28,480 shares during the last quarter.
JPMorgan Chase & Co. grew its holdings in shares of Privia Health Group by 8.4% in the third quarter.
JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock valued at $3,430,000 after acquiring an additional 14,641 shares in the last quarter. Finally, Nordea Investment Management AB increased its position in shares of Privia Health Group by 33.
1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after acquiring an additional 86,910 shares during the last quarter. 94.
48% of the stock is owned by hedge funds and other institutional investors. Privia Health Group Stock Up 0.3 %Shares of PRVA opened at $23.
46 on Friday. Privia Health Group, Inc. has a twelve month low of $15.
92 and a twelve month high of $26.04. The stock has a market cap of $2.
85 billion, a PE ratio of 234.62, a P/E/G ratio of 3.47 and a beta of 0.
88. The business’s 50-day moving average price is $23.68 and its 200-day moving average price is $21.
82. Wall Street Analyst Weigh InSeveral research firms have weighed in on PRVA. Piper Sandler boosted their price objective on Privia Health Group from $25.
00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. Stephens restated an “overweight” rating and set a $26.
00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Canaccord Genuity Group lifted their price objective on shares of Privia Health Group from $29.00 to $30.
00 and gave the stock a “buy” rating in a research report on Friday, February 28th. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research note on Friday, February 28th.
Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $30.00 price target on shares of Privia Health Group in a report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company’s stock.
According to MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $27.14.View Our Latest Research Report on PRVAInsider Buying and Selling at Privia Health GroupIn other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the firm’s stock in a transaction dated Wednesday, April 2nd.
The stock was sold at an average price of $22.38, for a total value of $125,999.40.
Following the sale, the chief financial officer now owns 179,676 shares of the company’s stock, valued at $4,021,148.88. This trade represents a 3.
04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 10.
70% of the company’s stock. About Privia Health Group (Free Report)Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Featured ArticlesFive stocks we like better than Privia Health Group3 Home Improvement Stocks that Can Upgrade Your Portfolio2 Strong Utilities Plays With Booming Earnings and Room to GrowInsider Trades May Not Tell You What You ThinkWhy Smart Investors Don’t Panic in Election SeasonHow the NYSE and NASDAQ are Different, Why That Matters to InvestorsNow Is the Time to Buy ServiceNow—The Rebound Is Real.
